Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Continuous vs Intermittent IV Iron Sucrose in Hemodialysis
NCT02787824Phase 4Completed
- Sponsor
- Papageorgiou General Hospital
- Start
- May 2016
- Primary completion
- Oct 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of iron sucrose in anemia of chronic kidney disease (CKD-A) (2 arms), sponsored by Papageorgiou General Hospital. Primary endpoint: Change of serum hemoglobin level at Month 4. Started May 2016; status: completed.
02
Drugs
iron sucrose
03
Conditions
anemia of chronic kidney disease (CKD-A)
Beyond the preview
Go deeper on NCT02787824.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02787824.